|Bid||3.110 x 3200|
|Ask||3.120 x 600|
|Day's Range||3.050 - 3.140|
|52 Week Range||0.680 - 3.160|
|PE Ratio (TTM)||-14.55|
|Earnings Date||Aug 7, 2017 - Aug 11, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||4.56|
NEW YORK, NY / ACCESSWIRE / July 12, 2017 / After a dismal 2016, the Biotech Industry has rallied back in 2017 as regulation fears have subsided. The iShares NASDAQ Biotechnology Index ETF and the SPDR ...
CORAL GABLES, Fla., June 26, 2017-- Catalyst Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating neuromuscular ...
Junior biotechs are attracting strong speculative interest that could offer outstanding returns for traders with well-honed risk management skills.